Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CONMED Corp
Report date October 01, 2020 · Filed October 01, 2020
Section 16 reporting ended · disclosed 2020-10-01. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2020 Filed Mar 3, 2020 21:26 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 30,000 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-20-008994 · form4.xml · derivative · entry 7 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2030-03-02 F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:26 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 400 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-008994 · form4.xml · derivative · entry 6 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 Underlying: Common Stock · 400 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:26 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-008994 · form4.xml · derivative · entry 5 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:26 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 98 | $94.64 | $9,274.72 |
DisclosureSEC source: 0001127602-20-008994 · form4.xml · nonDerivative · entry 4 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,280 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:26 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-008994 · form4.xml · nonDerivative · entry 3 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,378 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:26 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 122 | $94.64 | $11,546.08 |
DisclosureSEC source: 0001127602-20-008994 · form4.xml · nonDerivative · entry 2 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,978 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:26 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-008994 · form4.xml · nonDerivative · entry 1 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 28, 2019 Filed May 29, 2019 17:52 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 7,480 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-19-020110 · form4.xml · derivative · entry 3 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,407 Underlying: Common Stock · 7,480 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| May 28, 2019 Filed May 29, 2019 17:52 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 7,480 | $83.06 | $621,311.24 |
DisclosureSEC source: 0001127602-19-020110 · form4.xml · nonDerivative · entry 2 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.059 to $83.129. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| May 28, 2019 Filed May 29, 2019 17:52 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 7,480 | $39.87 | $298,227.60 |
DisclosureSEC source: 0001127602-19-020110 · form4.xml · nonDerivative · entry 1 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:32 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 400 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009947 · form4.xml · derivative · entry 7 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800 Underlying: Common Stock · 400 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:32 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009947 · form4.xml · derivative · entry 6 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Underlying: Common Stock · 500 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:32 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 32,000 | $0.00 Strike: $78.76 | $0.00 |
DisclosureSEC source: 0001127602-19-009947 · form4.xml · derivative · entry 5 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2029-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:32 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 119 | $78.76 | $9,372.44 |
DisclosureSEC source: 0001127602-19-009947 · form4.xml · nonDerivative · entry 4 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600 Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:32 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009947 · form4.xml · nonDerivative · entry 3 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:32 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 149 | $78.76 | $11,735.24 |
DisclosureSEC source: 0001127602-19-009947 · form4.xml · nonDerivative · entry 2 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,319 Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:32 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009947 · form4.xml · nonDerivative · entry 1 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 27, 2018 Filed Apr 30, 2018 18:47 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 4,113 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-18-015505 · form4.xml · derivative · entry 5 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,887 Underlying: Common Stock · 4,113 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| April 27, 2018 Filed Apr 30, 2018 18:47 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 296 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-18-015505 · form4.xml · derivative · entry 4 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,704 Underlying: Common Stock · 296 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| April 27, 2018 Filed Apr 30, 2018 18:47 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 4,409 | $64.98 | $286,496.82 |
DisclosureSEC source: 0001127602-18-015505 · form4.xml · nonDerivative · entry 3 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 968 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.92 to $65.01. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| April 27, 2018 Filed Apr 30, 2018 18:47 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 4,113 | $39.87 | $163,985.31 |
DisclosureSEC source: 0001127602-18-015505 · form4.xml · nonDerivative · entry 2 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,377 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 27, 2018 Filed Apr 30, 2018 18:47 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 296 | $41.93 | $12,411.28 |
DisclosureSEC source: 0001127602-18-015505 · form4.xml · nonDerivative · entry 1 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,264 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:55 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 35,000 | $0.00 Strike: $59.96 | $0.00 |
DisclosureSEC source: 0001127602-18-010005 · form4.xml · derivative · entry 7 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2028-03-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:55 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 400 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-010005 · form4.xml · derivative · entry 6 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,200 Underlying: Common Stock · 400 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:55 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-010005 · form4.xml · derivative · entry 5 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 500 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:55 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 119 | $59.96 | $7,135.24 |
DisclosureSEC source: 0001127602-18-010005 · form4.xml · nonDerivative · entry 4 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 968 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:55 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-010005 · form4.xml · nonDerivative · entry 3 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,087 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:55 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 149 | $59.96 | $8,934.04 |
DisclosureSEC source: 0001127602-18-010005 · form4.xml · nonDerivative · entry 2 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 687 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:55 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-010005 · form4.xml · nonDerivative · entry 1 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 18:29 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 1,600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009986 · form4.xml · derivative · entry 5 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600 Underlying: Common Stock · 1,600 shares Expires 2027-03-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 18:29 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 36,000 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-17-009986 · form4.xml · derivative · entry 4 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 Underlying: Common Stock · 36,000 shares Expires 2027-03-01 F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 18:29 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009986 · form4.xml · derivative · entry 3 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 500 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 18:29 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 164 | $41.93 | $6,876.52 |
DisclosureSEC source: 0001127602-17-009986 · form4.xml · nonDerivative · entry 2 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 336 Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 18:29 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009986 · form4.xml · nonDerivative · entry 1 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.